FER and FES tyrosine kinase fusions in follicular T-cell lymphoma

Blood. 2020 Feb 20;135(8):584-588. doi: 10.1182/blood.2019002401.

Authors

Koen Debackere^{1

2

3}, Jo-Anne van der Krogt², Thomas Tousseyn⁴, Julio Antonio Finalet Ferreiro², Katrien Van Roosbroeck², Lukas Marcelis⁴, Carlos Graux⁵, Daan Dierickx³, Geneviève Ameye², Peter Vandenberghe^{2

3}, Lucienne Michaux², Jan Cools^{1

2}, Iwona Wlodarska²

Affiliations

¹ Center for Cancer Biology, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.
² Center for Human Genetics, Katholieke Universiteit (KU) Leuven, Leuven, Belgium.
³ Department of Hematology, Universitair Ziekenhuis Leuven, Leuven, Belgium.
⁴ Translational Cell and Tissue Research Laboratory, KU Leuven, Leuven, Belgium; and.
⁵ Mont-Godinne University Hospital, Yvoir, Belgium.

PMID: 31746983
DOI: 10.1182/blood.2019002401

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Cytogenetic Analysis
Humans
Lymphoma, Follicular / genetics*
Lymphoma, T-Cell / genetics*
Middle Aged
Oncogene Fusion
Oncogene Proteins, Fusion / genetics*
Protein-Tyrosine Kinases / genetics*
Proto-Oncogene Proteins c-fes / genetics*

Substances

Oncogene Proteins, Fusion
proto-oncogene protein c-fes-fps
Protein-Tyrosine Kinases
FES protein, human
Proto-Oncogene Proteins c-fes